These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28849733)

  • 1. RNA editing of AZIN1 induces the malignant progression of non-small-cell lung cancers.
    Hu X; Chen J; Shi X; Feng F; Lau KW; Chen Y; Chen Y; Jiang L; Cui F; Zhang Y; Xu X; Li J
    Tumour Biol; 2017 Aug; 39(8):1010428317700001. PubMed ID: 28849733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.
    Shigeyasu K; Okugawa Y; Toden S; Miyoshi J; Toiyama Y; Nagasaka T; Takahashi N; Kusunoki M; Takayama T; Yamada Y; Fujiwara T; Chen L; Goel A
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.
    Chen L; Li Y; Lin CH; Chan TH; Chow RK; Song Y; Liu M; Yuan YF; Fu L; Kong KL; Qi L; Li Y; Zhang N; Tong AH; Kwong DL; Man K; Lo CM; Lok S; Tenen DG; Guan XY
    Nat Med; 2013 Feb; 19(2):209-16. PubMed ID: 23291631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
    Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
    J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
    Takeda S; Shigeyasu K; Okugawa Y; Yoshida K; Mori Y; Yano S; Noma K; Umeda Y; Kondo Y; Kishimoto H; Teraishi F; Nagasaka T; Tazawa H; Kagawa S; Fujiwara T; Goel A
    Cancer Lett; 2019 Mar; 444():127-135. PubMed ID: 30583079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer.
    Tay DJT; Song Y; Peng B; Toh TB; Hooi L; Toh DK; Hong H; Tang SJ; Han J; Gan WL; Chan THM; Krishna MS; Patil KM; Maraswami M; Loh TP; Dan YY; Zhou L; Bonney GK; Chow PK; Chen G; Chow EK; Le MTN; Chen L
    Mol Ther; 2021 Nov; 29(11):3258-3273. PubMed ID: 33974998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism for A-to-I RNA-edited AZIN1 in promoting tumor angiogenesis in colorectal cancer.
    Wei Y; Zhang H; Feng Q; Wang S; Shao Y; Wu J; Jin G; Lin W; Peng X; Xu X
    Cell Death Dis; 2022 Apr; 13(4):294. PubMed ID: 35365616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased HAGLR expression promotes non-small cell lung cancer proliferation and invasion via enhanced de novo lipogenesis.
    Lu C; Ma J; Cai D
    Tumour Biol; 2017 Apr; 39(4):1010428317697574. PubMed ID: 28443464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA editome imbalance in hepatocellular carcinoma.
    Qi L; Chan TH; Tenen DG; Chen L
    Cancer Res; 2014 Mar; 74(5):1301-6. PubMed ID: 24556721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An RNA editing fingerprint of cancer stem cell reprogramming.
    Crews LA; Jiang Q; Zipeto MA; Lazzari E; Court AC; Ali S; Barrett CL; Frazer KA; Jamieson CH
    J Transl Med; 2015 Feb; 13():52. PubMed ID: 25889244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AZIN1 RNA editing alters protein interactions, leading to nuclear translocation and worse outcomes in prostate cancer.
    Ghalali A; Wang L; Stopsack KH; Rice JM; Wu S; Wu CL; Zetter BR; Rogers MS
    Exp Mol Med; 2022 Oct; 54(10):1713-1726. PubMed ID: 36202978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT3 is correlated with the malignancy of non-small cell lung cancer.
    Xiong Y; Wang M; Zhao J; Wang L; Li X; Zhang Z; Jia L; Han Y
    Int J Oncol; 2017 Mar; 50(3):903-910. PubMed ID: 28197634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive RNA editome reveals that edited Azin1 partners with DDX1 to enable hematopoietic stem cell differentiation.
    Wang F; He J; Liu S; Gao A; Yang L; Sun G; Ding W; Li CY; Gou F; He M; Wang F; Wang X; Zhao X; Zhu P; Hao S; Ma Y; Cheng H; Yu J; Cheng T
    Blood; 2021 Nov; 138(20):1939-1952. PubMed ID: 34388251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis.
    Takahashi K; Shigeyasu K; Kondo Y; Gotoh K; Yano S; Umeda Y; Inokuchi T; Xu C; Yoshida K; Umeda H; Takahashi T; Takeda S; Yoshida R; Teraishi F; Kishimoto H; Mori Y; Noma K; Okugawa Y; Hiraoka S; Michiue H; Tazawa H; Matsushita O; Goel A; Fujiwara T
    J Crohns Colitis; 2023 May; 17(5):754-766. PubMed ID: 36528792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.
    Yue W; Zhao X; Zhang L; Xu S; Liu Z; Ma L; Jia W; Qian Z; Zhang C; Wang Y; Yang X
    Clin Lung Cancer; 2011 Jan; 12(1):43-50. PubMed ID: 21273179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kruppel-like factor 4 inhibits non-small cell lung cancer cell growth and aggressiveness by stimulating transforming growth factor-β1-meidated ERK/JNK/NF-κB signaling pathways.
    Yu R; Han L; Ni X; Wang M; Xue P; Zhang L; Yuan M
    Tumour Biol; 2017 Jun; 39(6):1010428317705574. PubMed ID: 28631556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma: transcriptome diversity regulated by RNA editing.
    Li Y; Chen L; Chan TH; Guan XY
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1843-8. PubMed ID: 23748106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.